US Secures 300 Million Doses of Potential AstraZeneca Covid-19 Vaccine
Team Udayavani, May 22, 2020, 1:26 PM IST
AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority to develop a coronavirus vaccine from the University of Oxford
The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s experimental Covid-19 vaccine
Alex Azar, U.S. Health Secretary said, “This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,”
The vaccine, previously known as ChAdOx1 nCoV-19 and now as AZD1222, was developed by the University of Oxford and licensed to AstraZeneca. The first doses of AZD1222 are expected to be delivered in October.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
MUST WATCH
Latest Additions
Bengaluru: Landlord rapes 20-yr-old woman at gunpoint; arrested
SC refuses to consider tour operator’s plea seeking inclusion of its name in Haj Organisers list
PM to lead main International Day of Yoga event at Mysuru
Indian GM Praggnanandhaa secures quarterfinal spot in Chessable Masters
SC refuses to consider tour operator’s plea seeking inclusion of its name in Haj Organisers list